Zobrazeno 1 - 10
of 577
pro vyhledávání: '"Ray, KK"'
Autor:
Watts, GF, Gidding, SS, Hegele, RA, Raal, FJ, Sturm, AC, Jones, LK, Sarkies, MN, Al-Rasadi, K, Blom, DJ, Daccord, M, De Ferranti, SD, Folco, E, Libby, P, Mata, P, Nawawi, HM, Ramaswami, U, Ray, KK, Stefanutti, C, Yamashita, S, Pang, J, Thompson, GR, Santos, RD
This contemporary, international, evidence-informed guidance aims to achieve the greatest good for the greatest number of people with familial hypercholesterolaemia (FH) across different countries. FH, a family of monogenic defects in the hepatic LDL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::178f2780d50a40cd0f8c2395f65be6ce
http://hdl.handle.net/10044/1/105073
http://hdl.handle.net/10044/1/105073
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
Autor:
Van de Borne, P, Peeters, A, Janssens, L, Leone, A, Lemmens, R, Verhaegen, A, De Meulemeester, M, Balthazar, Y, Heijmans, S, Calozet, Y, Paquot, N, Carlier, S, Hemelsoet, D, Bray, S, Ray, KK
Publikováno v:
Acta cardiologica, Vol. 136, no.1, p. 1-10 (2022)
Acta cardiologica
Acta cardiologica
BACKGROUND: Cardiovascular disease (CVD) is one of the leading causes of death in Belgium. Current strategies for the prevention and management of CVD focus on reducing low-density lipoprotein cholesterol (LDL-C) levels. This analysis assessed whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a58410b0f063cf38f8bd76d1e7ba0a4e
https://lirias.kuleuven.be/handle/20.500.12942/696043
https://lirias.kuleuven.be/handle/20.500.12942/696043
Autor:
Dharmayat, KI, Vallejo-Vaz, AJ, Stevens, CA, Lyons, AR, Catapano, AL, Freiberger, T, Hovingh, GK, Mata, P, Santos, R, Soran, H, Watts, GF, Raal, FJ, Ray, KK
Publikováno v:
E13
Autor:
Bhatt, Dl, Szarek, M, Pitt, B, Cannon, Cp, Leiter, La, Mcguire, Dk, Lewis, Jb, Riddle, Mc, Inzucchi, Se, Kosiborod, Mn, Cherney, Dzi, Dwyer, Jp, Scirica, Bm, Bailey, Cj, Díaz, R, Ray, Kk, Udell, Ja, Lopes, Rd, Lapuerta, P, Steg, Gabriel, P, Lauro, D
Publikováno v:
Bhatt, D L, Szarek, M, Pitt, B, Cannon, C P, Leiter, L A, McGuire, D K, Lewis, J B, Riddle, M C, Inzucchi, S E, Kosiborod, M N, Cherney, D Z I, Dwyer, J P, Scirica, B M, Bailey, C J, Díaz, R, Ray, K K, Udell, J A, Lopes, R D, Lapuerta, P, Steg, P G & SCORED Investigators 2021, ' Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease ', The New England Journal of Medicine, vol. 384, no. 2, pp. 129-139 . https://doi.org/10.1056/NEJMoa2030186
NEW ENGLAND JOURNAL OF MEDICINE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
NEW ENGLAND JOURNAL OF MEDICINE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
In a trial involving 10,584 patients with diabetes and chronic kidney disease, sotagliflozin resulted in fewer total deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure than placebo. Diarrhea, my
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9705eeadc025b1e0478507d16cdaa4
https://pure.au.dk/portal/da/publications/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease(6bc50c6b-8a7a-4eea-bd9e-9032680e8b64).html
https://pure.au.dk/portal/da/publications/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease(6bc50c6b-8a7a-4eea-bd9e-9032680e8b64).html
Publikováno v:
Yearbook of Paediatric Endocrinology.
Autor:
Landmesser, U, Haghikia, A, Leiter, LA, Wright, RS, Kallend, D, Wijngaard, P, Stoekenbroek, R, Kastelein, JJP, Ray, KK
INTRODUCTION: siRNA-based targeting of PCSK9 represents a novel therapeutic approach that may provide a convenient, infrequent and safe dosing schedule to robustly lower LDL-C. Given the long duration of action, however, establishing safety in partic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::a1871284f9cf60ccf2ac215121c1b7bd
http://hdl.handle.net/10044/1/78216
http://hdl.handle.net/10044/1/78216
Autor:
Brandts, J, Ray, KK
Lifetime medication burden from current approaches to LDL-cholesterol (LDL-C) lowering is reliant on small molecules requiring daily dosing with the burden of responsibility placed upon patients. Patient-related factors (risk perception, health liter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::e25f31c73bd69f7aef9df5d223cb5596
http://hdl.handle.net/10044/1/77213
http://hdl.handle.net/10044/1/77213
Autor:
Wilemon, KA, Patel, J, Aguilar-Salinas, C, Ahmed, CD, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, LM, Bogsrud, MP, Braun, LT, Brunham, L, Catapano, AL, Cillikova, K, Corral, P, Cuevas, R, Defesche, JC, Descamps, OS, de Ferranti, S, Eisele, JL, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, IM, Gesztes, AG, Groselj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, GK, Izar, MC, Jamison, A, Karlsson, GN, Kayikcioglu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, MM, Lopez, G, Martinez, TL, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Mensah, GA, Miserez, AR, Neely, D, Nicholls, SJ, Nohara, A, Nordestgaard, BG, Ose, L, Pallidis, A, Pang, J, Payne, J, Peterson, AL, Popescu, MP, Puri, R, Ray, KK, Reda, A, Sampietro, T, Santos, RD, Schalkers, I, Schreier, L, Shapiro, MD, Sijbrands, E, Soffer, D, Stefanutti, C, Stoll, M, Sy, RG, Tamayo, ML, Tilney, MK, Tokgozoglu, L, Tomlinson, B, Vallejo-Vaz, AJ, Vazquez-Cardenas, A, de Luca, PV, Wald, DS, Watts, GF, Wenger, NK, Wolf, M, Wood, D, Zegerius, A, Gaziano, TA, Gidding, SS, Global Familial
Publikováno v:
JAMA Cardiology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
ImportanceFamilial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::02f2867a3320f79afe99cde908232413
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2046
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2046
Autor:
Mach, F, Baigent, C, Catapano, AL, Koskinas, KC, Casula, M, Badimon, L, Chapman, MJ, De Backer, GG, Delgado, V, Ference, BA, Graham, IM, Halliday, A, Landmesser, U, Mihaylova, B, Pedersen, TR, Riccardi, G, Richter, DJ, Sabatine, MS, Taskinen, MR, Tokgozoglu, L, Wiklund, O, Mueller, C, Drexel, H, Aboyans, V, Corsini, A, Doehner, W, Farnier, M, Gigante, B, Kayikcioglu, M, Krstacic, G, Lambrinou, E, Lewis, BS, Masip, J, Moulin, P, Petersen, S, Petronio, AS, Piepoli, MF, Pinto, X, Raber, L, Ray, KK, Reiner, Z, Riesen, WF, Roffi, M, Schmid, JP, Shlyakhto, E, Simpson, IA, Stroes, E, Sudano, I, Tselepis, AD, Viigimaa, M, Vindis, C, Vonbank, A, Vrablik, M, Vrsalovic, M, Gomez, JLZ, Collet, JP, European Soc Cardiology, European Atherosclerosis Soc
Publikováno v:
European Heart Journal, 41(1), 111-188. OXFORD UNIV PRESS
EUROPEAN HEART JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
EUROPEAN HEART JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::92c3c4ceca1dcf8470d39ee0369189c6
https://academic.oup.com/eurheartj/article/41/1/111/5556353
https://academic.oup.com/eurheartj/article/41/1/111/5556353
Autor:
Wilemon, KA, Patel, J, Aguilar-Salinas, C, Ahmed, CD, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, LM, Bogsrud, MP, Braun, LT, Brunham, L, Catapano, AL, Cillíková, K, Corral, P, Cuevas, R, Defesche, JC, Descamps, OS, De Ferranti, S, Eiselé, J-L, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, IM, Gesztes, ÁG, Grošelj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, GK, Izar, MC, Jamison, A, Karlsson, GN, Kayikçioglu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, MM, López, G, Martinez, TL, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Mensah, GA, Miserez, AR, Neely, D, Nicholls, SJ, Nohara, A, Nordestgaard, BG, Ose, L, Pallidis, A, Pang, J, Payne, J, Peterson, AL, Popescu, MP, Puri, R, Ray, KK, Reda, A, Sampietro, T, Santos, RD, Schalkers, I, Schreier, L, Shapiro, MD, Sijbrands, E, Soffer, D, Stefanutti, C, Stoll, M, Sy, RG, Tamayo, ML, Tilney, MK, Tokgözoglu, L, Tomlinson, B, Vallejo-Vaz, AJ, Vazquez-Cárdenas, A, De Luca, PV, Wald, DS, Watts, GF, Wenger, NK, Wolf, M, Wood, D, Zegerius, A, Gaziano, TA, Gidding, SS
Importance Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::4e6b2e513615db903a218c6cf941805c
http://hdl.handle.net/10044/1/78721
http://hdl.handle.net/10044/1/78721